Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings to January 31, 2024
17 Januar 2024 - 5:00PM
Postponement of the decision on the
adoption of a sale plan (plan de
cession) and the opening of judicial liquidation
proceedings to January 31, 2024
Paris, France, January 17,
2024 – 5:00 pm
(CET) – Pixium Vision SA (Euronext Growth Paris -
FR001400JX97; Mnemo: ALPIX), a bioelectronics company developing
innovative vision systems to enable patients who have lost their
sight to live more independent lives, announces that the Paris
Commercial Court has postponed its decision on the takeover offer
filed on November 20, 2023 and the opening of judicial liquidation
proceedings to January 31, 2024.
The Company will apply to Euronext Paris for its
shares to be suspended from that date.
Pixium draws investors’ attention to the fact
that, given the price offered by the prospective buyer and the
Company’s level of indebtedness, the sale proceeds received in the
event of a favourable decision by the Commercial Court will not
allow a total or partial reimbursement of shareholders.
About Pixium Vision
Pixium Vision is creating a
world of bionic vision for those who have lost their sight,
enabling them to regain visual perception and greater autonomy.
Pixium Vision’s bionic vision systems are associated with a
surgical intervention and a rehabilitation period. Prima System
sub-retinal miniature photovoltaic wireless implant is in clinical
testing for patients who have lost their sight due to outer retinal
degeneration, initially for atrophic dry age-related macular
degeneration (dry AMD). Pixium Vision collaborates closely with
academic and research partners, including some of the most
prestigious vision research institutions in the world, such as
Stanford University in California, Institut de la Vision in Paris,
Moorfields Eye Hospital in London, Institute of Ocular Microsurgery
(IMO) in Barcelona, University hospital in Bonn, and UPMC in
Pittsburgh, PA. The Company is EN ISO 13485 certified and qualifies
as “Entreprise Innovante” by Bpifrance.
For more information:
http://www.pixium-vision.com/fr
Follow us on @PixiumVision;
www.facebook.com/pixiumvision
www.linkedin.com/company/pixium-vision
Contacts
Investor
RelationsPixium VisionOffer NonhoffChief
Financial Officerinvestors@pixium-vision.com |
Media
Relations Rose Piquante ConsultingSophie
BaumontSophie.baumont@rosepiquante-consulting.com+33 6 27 74 74
49 |
- Pixium - new Court's decision date - 17.01.2024
Pixium Vision (EU:ALPIX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Pixium Vision (EU:ALPIX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024